...on-track to complete its current fourth quarter on a strong note and, most importantly, has planted strategic investments domestically and abroad in anticipation of a blockbuster Fiscal Year 2021, driven primarily by the expected favorable reforms and legislation at the federal level for the rapidly growing cannabis and CBD industries.
the Company has structured itself for advancing capitalization on a spectrum of advantageous market opportunities with the Chief Executive appointments of Mr. Darrel Courtney, to lead GreenGro Tech, and Mr. Tom Schaefer to drive the growth in its CBD Ventures/GenoBreeding division.
Management has been focused on the accelerated completion of the Genobreeding Seed Genetics program. Full scale operations have recommenced, and forthcoming announcements regarding progress are expected.
GreenGro Technologies Inc. and its subsidiaries do not sell or distribute any products that are in violation of the United States Controlled Substance Act (US.CSA).
These products are not for use or sale to persons under the age of 21. These products should be used only as directed on the label. They should not be used if pregnant or nursing. Consult with a physician before use if you have a serious medical condition or use prescription medications. The doctor’s advice should be sought before using these and any other supplemental dietary products. All trademarks and copyrights are property of their respective owners and are not affiliated with nor do they endorse these products. These statements have not been evaluated by the FDA. These products are not intended to diagnose, treat, cure or prevent any disease. By using this site, you agree to follow the Privacy Policy and all Terms & Conditions printed on this site. Void Where Prohibited by Law.
